The Cost of HIV Disease in Northern Italy: The Payer's Perspective

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2011-07-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1097/QAI.0b013e31821fdee2PMID 21546850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changing Rate of Non-B Subtypes and Coinfection with Hepatitis B/C Viruses in Newly Diagnosed HIV Type 1 Individuals in Spain

  2011cited by this paper
• Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 μl

  2010cited by this paper
• Contemporary costs of HIV healthcare in the HAART era

  2010cited by this paper
• Antiretroviral therapy and management of HIV infection.

  2010cited by this paper
• Cost of medical care for HIV‐infected patients within a regional population from 1997 to 2006

  2008cited by this paper
• Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

  2008cited by this paper
• Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

  2007cited by this paper
• Analysis of Treatment Costs for HIV RNA Reductions and CD4 Increases for Darunavir Versus Other Antiretrovirals in Treatment-Experienced, HIV–Infected Patients

  2007cited by this paper
• Cost of a dedicated ART clinic.

  2007cited by this paper
• Predicting HIV care costs using CD4 counts from clinical trials.

  2007cited by this paper
• Cost to patients of obtaining treatment for HIV/AIDS in South Africa.

  2007cited by this paper
• Costs of care provided in a university hospital for children exposed to or infected with the HIV/AIDS.

  2007cited by this paper
• The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

  2006cited by this paper
• Hospital and Outpatient Health Services Utilization Among HIV-Infected Adults in Care 2000–2002

  2005cited by this paper
• Financing antiretroviral treatment and primary health care services.

  2005cited by this paper
• Coinfection with HIV and hepatitis C virus in injection drug users and minority populations.

  2005cited by this paper
• The cost of a rapid-test VCT clinic in South Africa.

  2005cited by this paper
• Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures.

  2004cited by this paper
• The high cost of medical care for patients who present late (CD4<200 cells/μL) with HIV infection

  2004cited by this paper
• Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

  2003cited by this paper
• Hepatitis C and progression of HIV disease.

  2002cited by this paper
• Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

  2002influential reference
• Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

  2002cited by this paper
• Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

  2002cited by this paper
• Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.

  2002cited by this paper
• Providing antiretroviral therapy for HIV infection.

  2001cited by this paper
• Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy

  2001cited by this paper
• Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

  2000cited by this paper
• as an health

  1999cited by this paper
• Modeling risk using generalized linear models.

  1999cited by this paper
• Methods for the economic evaluation of health care programmes

  1987cited by this paper
• Use of Ranks in One-Criterion Variance Analysis

  1952cited by this paper
• On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

  1947cited by this paper

• Assessing the efficiency and effectiveness of community-based voluntary counseling and testing for HIV in Turin: insights from the fast-track cities initiative - a cross-sectional study

  2025cites this paper
• Evaluation of epidemiological and economic consequences due to the delay in treatment of hiv-positive patients caused by the covid-19 pandemic

  2021cites this paper
• Valutazione delle conseguenze epidemiologiche ed economiche generate dal ritardo di trattamento dei pazienti HIV-positivi causato dalla pandemia COVID-19

  2021cites this paper
• Treatment cost of HIV/AIDS in Turkey

  2020cites this paper
• HTA and HIV: The Case of Dual NRTI Backbones in the Italian Setting

  2020cites this paper
• PIN38 Cost-Effectiveness of Expanded HIV Screening Among Adult Population in Italy

  2020cites this paper
• Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice

  2020cites this paper
• Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi

  2018cites this paper
• Model of care for HIV infection in Ireland

  2016influential citation
• La conta dei linfociti nel monitoraggio del paziente con infezione da HIV: evidenze per un impiego ragionato@@@Is it time to change the timeline of lymphocyte T CD4+ count in clinical practice?

  2016cites this paper
• HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy

  2016cites this paper
• Early Treatment in HIV Patients: A Cost–Utility Analysis from the Italian Perspective

  2016influential citation
• HIV+ patients and gender differences: evidence from an Italian cohort

  2016cites this paper
• Resource utilisation and cost of ambulatory HIV care in a regional HIV centre in Ireland: a micro-costing study

  2015cites this paper
• New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)

  2015cites this paper
• reveals that parasites interact most via shared resources Analysis of a summary network of co-infection in humans

  2014cites this paper
• Health technology assessment in the HIV setting: the case of monotherapy.

  2014cites this paper
• Antiretroviral treatment‐based cost saving interventions may offset expenses for new patients and earlier treatment start

  2014cites this paper
• Analysis of a summary network of co-infection in humans reveals that parasites interact most via shared resources

  2014cites this paper
• Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World

  2013cites this paper
• The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected Patients

  2013cites this paper
• Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting

  2013cites this paper
• Economic Impact of the Highly Active Antiretroviral Pharmacotherapy on Cost and HIV/AIDS Control in Bulgaria

  2013cites this paper
• The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection.

  2012cites this paper
• Eleventh International Congress on Drug Therapy in HIV Infection

  2012cites this paper
• Analysis of the evolution of direct costs of antiretroviral delivery in Argentina

  2012cites this paper
• Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy

  2012influential citation
• Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy

  2012influential citation
• Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy

  2012influential citation
• The effect on survival of a multidimensional intervention project (SEAD) in HIV/AIDS patients with follow‐up and adherence (FUP/ADH) barriers

  2012cites this paper
• Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection

  2012cites this paper
• Clinicoeconomics and Outcomes Research Dovepress Cost of Haart in Italy: Multicentric Evaluation and Determinants from a Large Hiv Outpatient Cohort

  year unknowncites this paper
• Clinicoeconomics and Outcomes Research

  year unknowncites this paper